Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Consulting Services RFPsConsulting Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More consulting services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Assessing the Feasibility of Incorporating Mechanisms in…

U.S. National Institutes of Health·United States of America

Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required)

Closes 11/16/2029$250k – $500kGrants Notice
Get bids like this by emailBid source

Description

This NIH Notice of Funding Opportunity (NOFO) seeks applications for multi‑site feasibility clinical trials of mind‑and‑body interventions (e.g., meditation, yoga, acupuncture, music) aimed at restoring whole‑person health. The award is a cooperative agreement (R33) with a ceiling of $500,000. Projects must involve at least two geographically distinct sites, demonstrate fidelity of intervention delivery, assess recruitment/retention, collect comprehensive clinical and mechanistic data, and explore correlations between emotional‑well‑being mechanisms and health outcomes using the Whole Person Health Index. Eligible applicants include a broad range of public, nonprofit, and for‑profit entities (excluding foreign organizations). The anticipated award date is July 13 2027, with project start around July 20 2027. • Multi‑site feasibility trial (≥2 sites) of mind‑body therapies • Focus on whole‑person health restoration and emotional‑well‑being mechanisms • Required use of Whole Person Health Index as primary outcome • Cooperative agreement (R33) with up to $500 K funding ceiling • Open to U.S. public, nonprofit, and for‑profit entities (no foreign applicants) • Submission deadline: 11 / 16 / 2029; award expected 07 / 13 / 2027.

Attached files

Contact

Jennifer N. Baumgartner, Ph.D.(Scientific/Research Contact)

[email protected]

(301) 402-4084

Key dates

Opened
7/8/2025
Closes
11/16/2029
Projected award
7/13/2027
Duration
4 years

Last updated

Details

Type
Grants Notice
Industry
Consulting Services
NAICS
541715
Solicitation №
PAR-28-091

Budget estimate

$250,000 – $500,000

The NOFO lists an award ceiling of $500,000 and does not specify a minimum. Typical NIH R33 feasibility awards range from $250 K to the full ceiling, depending on scope, number of sites, and personnel costs. Assuming a moderate‑size consortium (2‑3 sites) with principal investigators, research staff, and data‑management expenses, a realistic award would fall between $250,000 and $500,000.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 91%

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

Closes 11/17/2026Opened 12/20/2023

U.S. National Institutes of Health·United States of America

90% match

Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required)

Closes 6/7/2028Opened 5/28/2025

U.S. National Institutes of Health·United States of America

89% match

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

Closes 11/17/2026Opened 12/20/2023

U.S. National Institutes of Health·United States of America

87% match

Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

Closes 7/30/2027Opened 9/29/2026

U.S. National Institutes of Health·United States of America

87% match

Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)

Closes 1/7/2028Opened 4/1/2021

U.S. National Institutes of Health·United States of America

87% match

NIH Pragmatic Trials Conducted in Health Care Systems

Closes 2/22/2027Opened 4/29/2026

U.S. National Institutes of Health·United States of America

87% match

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Closes 6/16/2028Opened 3/16/2026

U.S. National Institutes of Health·United States of America

87% match

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

86% match

NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)

Closes 3/9/2029Opened 8/28/2025

U.S. National Institutes of Health·United States of America

86% match

Feasibility Studies to Inform the Design of Future Clinical Trials

Closes 2/15/2027Opened 4/28/2026

U.S. National Institutes of Health·United States of America

86% match

Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional)

Closes 11/5/2029Opened 9/29/2025

U.S. National Institutes of Health·United States of America

85% match

Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)

Closes 7/16/2029Opened 1/26/2026

U.S. National Institutes of Health·United States of America

84% match

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

84% match

Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

Closes 2/15/2027Opened 7/1/2026

U.S. National Institutes of Health·United States of America

84% match

Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

84% match

Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)

Closes 10/27/2027Opened 5/11/2021

U.S. National Institutes of Health·United States of America

84% match

HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

Closes 2/9/2029Opened 6/4/2026

U.S. National Institutes of Health·United States of America

84% match

Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

84% match

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

84% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

84% match

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

Closes 11/2/2028Opened 5/9/2025

U.S. National Institutes of Health·United States of America

84% match

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

84% match

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

Closes 2/20/2029Opened 5/28/2025

U.S. National Institutes of Health·United States of America

84% match

NIH Research Program Projects (Parent P01 Clinical Trial Optional)

Closes 5/25/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

84% match

BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)

Closes 1/28/2027Opened 3/19/2024